Standard Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-399,496
| Closed | -$15M | – | 9 |
|
|
2017
Q3 | $15M | Hold |
399,496
| – | – | 3.16% | 8 |
|
|
2017
Q2 | $19.1M | Hold |
399,496
| – | – | 2.73% | 11 |
|
|
2017
Q1 | $18.2M | Sell |
399,496
-375,892
| -48% | -$17.1M | 2.5% | 11 |
|
|
2016
Q4 | $25M | Hold |
775,388
| – | – | 4.58% | 6 |
|
|
2016
Q3 | $26.5M | Hold |
775,388
| – | – | 4.84% | 6 |
|
|
2016
Q2 | $26.2M | Sell |
775,388
-32,262
| -4% | -$1.09M | 3.55% | 7 |
|
|
2016
Q1 | $42.8M | Buy |
807,650
+67,650
| +9% | +$3.58M | 4.27% | 8 |
|
|
2015
Q4 | $56.8M | Buy |
740,000
+30,000
| +4% | +$2.3M | 3.97% | 7 |
|
|
2015
Q3 | $29.2M | Buy |
710,000
+279,465
| +65% | +$11.5M | 2.06% | 9 |
|
|
2015
Q2 | $30.4M | Buy |
430,535
+148,251
| +53% | +$10.5M | 1.72% | 10 |
|
|
2015
Q1 | $25.1M | Buy |
282,284
+267,032
| +1,751% | +$23.7M | 1.54% | 9 |
|
|
2014
Q4 | $1.35M | Buy |
15,252
+9,520
| +166% | +$844K | 0.07% | 95 |
|
|
2014
Q3 | $556K | Hold |
5,732
| – | – | 0.03% | 145 |
|
|
2014
Q2 | $527K | Sell |
5,732
-6,634
| -54% | -$610K | 0.03% | 138 |
|
|
2014
Q1 | $865K | Buy |
12,366
+3,206
| +35% | +$224K | 0.08% | 128 |
|
|
2013
Q4 | $527K | Buy |
+9,160
| New | +$527K | 0.04% | 123 |
|